Black Diamond Therapeutics, Inc.
BDTX
$1.60
$0.010.63%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.99M | -15.56M | -19.91M | -18.23M | -19.41M |
| Total Depreciation and Amortization | 85.00K | 86.00K | 86.00K | 86.00K | 86.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.66M | 1.67M | 4.88M | 1.51M | 1.44M |
| Change in Net Operating Assets | -816.00K | 2.48M | 217.00K | -4.57M | 3.93M |
| Cash from Operations | -15.06M | -11.32M | -14.73M | -21.20M | -13.96M |
| Capital Expenditure | -- | -- | -- | -- | 0.00 |
| Sale of Property, Plant, and Equipment | 8.00K | 48.00K | 38.00K | -- | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 27.76M | 2.15M | 702.00K | -13.73M | 12.25M |
| Cash from Investing | 27.77M | 2.19M | 740.00K | -13.73M | 12.25M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 291.00K | -- | 21.38M | 4.13M | -- |
| Repurchase of Common Stock | -- | -252.00K | -- | -- | -46.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 291.00K | -252.00K | 21.38M | 4.13M | -46.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.01M | -9.38M | 7.39M | -30.80M | -1.75M |